Genetic Factors That Influence Your Tirzepatide Response Timing The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) variants that relate to GLP-1 and related signaling pathways
In studies, participants lost an average of 15% body weight over 68 weeks
Heres how you can survive and even thrive during the Christmas holidays without compromising your progress
Before beginning any kind of treatment, it is important to take the necessary precautions
Protocol 1: Conservative sub-therapeutic approach Goal: Target inflammation with minimal metabolic impact Starting dose: 0.5 to 1.0 mg tirzepatide weekly Escalation: Increase by 0.25 to 0.5 mg every 4 to 6 weeks based on inflammatory marker response Target maintenance: The lowest dose that produces measurable CRP/IL-6 reduction Monitoring schedule: Baseline: hsCRP, IL-6, complete metabolic panel, body weight Week 4: hsCRP, symptom assessment Week 8: hsCRP, IL-6, body weight Every 8 weeks thereafter: full inflammatory panel Duration: Minimum 12 weeks to assess response, with ongoing reassessment Best for: Normal-weight individuals with elevated inflammatory markers, autoimmune patients who cannot afford weight loss This protocol uses the compounded tirzepatide dosage calculator approach since standard vials are not designed for sub-2.5 mg dosing